Latest Market Announcements News

The ASX has suspended trading in Aspermont Limited, Koba Resources, and WA Kaolin due to their failure to lodge required periodic reports on time. The suspension may be lifted if the companies submit their reports promptly.

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for over 60 of its ETFs following the December 2025 distribution period, offering investors a clear path to reinvest dividends.

Betashares Capital Ltd has released estimated distribution amounts for over 70 ETFs for the December 2025 period, highlighting income opportunities across a broad spectrum of funds. Investors should note key dates and the operation of the Distribution Reinvestment Plan.

The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.

Meteoric Resources NL has voluntarily suspended trading of its shares on the ASX pending a key announcement addressing media speculation about its Preliminary License approval process.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Superior Resources Limited has voluntarily suspended trading of its shares pending a Supreme Court hearing on the validation of uncleansed shares, with a prospectus filing expected to follow.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.

Bentley Capital Limited has voluntarily suspended trading of its shares on the ASX pending a market announcement addressing a recent price and volume query. The suspension is expected to last until early November, signaling heightened regulatory scrutiny.